SAN DIEGO, Jan. 6, 2011 /PRNewswire/ — Cardium Therapeutics
CXM) today announced today that it is scheduled to present at
the OneMedForum Finance Conference for Emerging Healthcare and Life
Sciences Companies on Tuesday, January 11, 2011 at 3:00 p.m. (PT)
at the Sir Francis Drake Hotel in San Francisco, CA. The
slide presentation will be available at the company’s website at
OneMedForum takes place January 11-13,
2011 in San Francisco, CA during the world’s largest
gathering of healthcare financiers and executives. The Forum
will feature presentations by over 100 of the world’s most
promising emerging life science public and private companies.
In 2010, over 1,000 investors participated in the conference.
To learn more about the forum, visit www.onemedplace.com.
Cardium is focused on the acquisition and strategic development
of new and innovative bio-medical product opportunities and
businesses that have the potential to address significant unmet
medical needs and definable pathways to commercialization,
partnering and other economic monetizations. Cardium’s
current investment portfolio includes the Tissue Repair Company,
Cardium Biologics, and the Company’s in-house MedPodium healthy
lifestyle product platform. The Company’s lead product
candidates include Excellagen™ topical gel for wound care
management, and Generx® DNA-based angiogenic biologic for
patients with coronary artery disease. In